Year: 2011
Type: article
Abstract: New-onset diabetes after transplan-tation (NODAT) is a serious and fre-quent metabolic complication after renal transplantation. This entity is cur-rently well defined since the publication of the International Consensus Guidelines in 2003. Here, we review the factors con-tributing to the risk of NODAT and the strategies related tomodifiable factors, with emphasis on practical issues. Recognizing these factors may help clinicians to eval-uate prospectively appropriate prevention strategies to minimize the risk of NODAT. Over the past 50 years, the concept of NODAT has evolved in terms of name and definition. Before 2003, de novo diabetes that developed after transplantation was
Source: Diabetes Care
DOI: 10.2337/dc11-1230
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2107522068
